✦ LIBER ✦

A placebo-controlled, double-blind, flexible dosage study to evaluate the efficacy and tolerability of sertraline in the treatment of DSM-IV generalized anxiety disorder

✍ Scribed by O. Brawman-Mintzer; K. Rickels; M. Rynn; R. Knapp

Book ID: 119576344
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 115 KB
Volume: 12
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(02)80588-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Deramciclane in the treatment of general

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

✍ Y. Lecrubier; A. J. Puech; A. Azcona; P. E. Bailey; X. Lataste 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 594 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety

✍ M. Linden; D. Hadler; S. Hofmann 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Generalized anxiety disorders are frequent, chronic, and disabling illnesses for which so far ideal drug treatment is not available. A new promising anxiolytic drug is DN-2327, a non-benzodiazepine isoindoline derivative, which has shown in animals to have anxiolytic, taming, antiaggressive, and ant

Efficacy and tolerability of duloxetine

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo